CorMedix Inc. Research And Development Expense

• CorMedix Inc. showed an increase of +390.4% in Research And Development Expense from 2024 to 2025.
• This data is from CorMedix Inc.'s annual report (Form 10-K), filed with the SEC on March 5, 2026.
• XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 16 years of available data (2010 to 2025), CorMedix Inc.'s Research And Development Expense has grown by 251.9%.
• Historical annual values: Fiscal year 2025: $19.33 million | Fiscal year 2024: $3.94 million | Fiscal year 2023: $13.16 million | Fiscal year 2022: $10.68 million | Fiscal year 2021: $13.13 million | Fiscal year 2020: $13.38 million | Fiscal year 2019: $11.05 million | Fiscal year 2018: $18.82 million | Fiscal year 2017: $24.49 million | Fiscal year 2016: $15.74 million | Fiscal year 2015: $6.28 million | Fiscal year 2014: $1.32 million | Fiscal year 2013: $1.23 million | Fiscal year 2012: $1.14 million | Fiscal year 2011: $4.10 million | Fiscal year 2010: $5.49 million.
• Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: June 22, 2026